Aptus Capital Advisors LLC Has $740,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Aptus Capital Advisors LLC boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 15.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,304 shares of the company’s stock after purchasing an additional 314 shares during the quarter. Aptus Capital Advisors LLC’s holdings in HCA Healthcare were worth $740,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare in the 2nd quarter worth $28,000. Bangor Savings Bank lifted its holdings in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC grew its holdings in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares in the last quarter. Finally, Atlantic Edge Private Wealth Management LLC acquired a new position in HCA Healthcare during the 4th quarter worth approximately $27,000. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft raised their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Barclays upped their target price on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research note on Monday, August 19th. Wells Fargo & Company boosted their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 30th. Finally, UBS Group boosted their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Four analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $356.17.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the transaction, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The disclosure for this sale can be found here. Insiders have sold 8,844 shares of company stock worth $3,185,932 over the last quarter. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 0.7 %

HCA stock opened at $395.59 on Tuesday. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $395.91. The company has a market cap of $103.61 billion, a PE ratio of 19.72, a price-to-earnings-growth ratio of 1.52 and a beta of 1.68. The business has a 50-day simple moving average of $350.82 and a 200 day simple moving average of $333.94.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the previous year, the business earned $4.29 earnings per share. The company’s revenue was up 10.3% on a year-over-year basis. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 22.5 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio is 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.